The 37 rating InvestorsObserver gives to Stealth BioTherapeutics Corp (MITO) stock puts it near the bottom of the Biotechnology industry. In addition to scoring higher than 28 percent of stocks in the Biotechnology industry, MITO’s 37 overall rating means the stock scores better than 37 percent of all stocks.
What do These Ratings Mean?
Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 37 means the stock is more attractive than 37 percent of stocks.
Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.
What's Happening With Stealth BioTherapeutics Corp Stock Today?
Stealth BioTherapeutics Corp (MITO) stock is trading at $1.42 as of 10:38 AM on Friday, Jan 8, a rise of $0.04, or 2.9% from the previous closing price of $1.38. The stock has traded between $1.39 and $1.45 so far today. Volume today is light. So far 122,117 shares have traded compared to average volume of 815,884 shares.
Click Here to get the full Stock Score Report on Stealth BioTherapeutics Corp (MITO) Stock.
